Abstract
Background
Macrosomia and child obesity are growing health-care issues worldwide. The purpose of the study was to evaluate how extremely high or low birth weight affects metabolic markers evaluated in newborn screening.
Methods
The study was register-based and included full-term singletons born in Iceland from 2009 to 2012 with newborn screening samples taken 72–96 h after birth. Three groups based on birth weight were compared: low birth weight (<2500 g), appropriate-for-gestational age, and extreme macrosomia (≥5000 g). The comparison was adjusted for possible confounding factors.
Results
Compared to appropriate-for-gestational age neonates, both low birth weight and extreme macrosomia were associated with higher levels of glutamic acid. The amino acids alanine and threonine were increased in low birth weight neonates. Free carnitine and some medium- and long-chain acylcarnitines were higher in low birth weight infants. Hydroxybutyrylcarnitine was lower in low birth weight infants, but higher in extremely macrosomic neonates. Acetylcarnitine was higher in low birth weight and extremely macrosomic neonates. Succinylcarnitine was lower and hexadecenoylcarnitine higher in macrosomic newborns.
Conclusion
Low birth weight and extremely macrosomic neonates show distinctive differences in their metabolomic profile compared to appropriate-for-gestational age newborns. The differences are not explained by gestational age.
Impact
-
The key message of this article is that both low birth weight and extremely macrosomic newborns show dissimilar metabolomic profiles compared to appropriate-for-gestational age neonates.
-
The article contributes to knowledge on what affects evaluation of results in newborn screening.
-
The impact of this article is to provide information on metabolism at both ends of the birth weight range after accounting for confounding factors including gestational age.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
137,91 €
only 10,61 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.



References
Almannai, M., Marom, R. & Sutton, V. R. Newborn screening: a review of history, recent advancements, and future perspectives in the era of next generation sequencing. Curr. Opin. Pediatr. 28, 694–699 (2016).
Clark, R. H., Kelleher, A. S., Chace, D. H. & Spitzer, A. R. Gestational age and age at sampling influence metabolic profiles in premature infants. Pediatrics 134, e37–e46 (2014).
Vieira Neto, E. et al. Analysis of acylcarnitine profiles in umbilical cord blood and during the early neonatal period by electrospray ionization tandem mass spectrometry. Braz. J. Med. Biol. Res. 45, 546–556 (2012).
Ryckman, K. K., Berberich, S. L., Shchelochkov, O. A., Cook, D. E. & Murray, J. C. Clinical and environmental influences on metabolic biomarkers collected for newborn screening. Clin. Biochem. 46, 133–138 (2013).
Gucciardi, A. et al. Analysis and interpretation of acylcarnitine profiles in dried blood spot and plasma of preterm and full-term newborns. Pediatr. Res. 77, 36–47 (2015).
Yang, L., Zhang, Y., Yang, J. & Huang, X. Effects of birth weight on profiles of dried blood amino-acids and acylcarnitines. Ann. Clin. Biochem. 55, 92–99 (2018).
Butte, N. F. et al. Global metabolomic profiling targeting childhood obesity in the Hispanic population. Am. J. Clin. Nutr. 102, 256–267 (2015).
Zhao, X. et al. Using metabolomic profiles as biomarkers for insulin resistance in childhood obesity: a systematic review. J. Diabetes Res. 2016, 1–12 (2016).
Guasch-Ferré, M. et al. Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care 39, 833–846 (2016).
Menni, C. et al. Biomarkers for Type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes 62, 4270–4276 (2013).
Donovan, B., Fleener, D., Bedell, B., Borowski, K. & Ryckman, K. Pregnancy-related changes of amino acid and acylcarnitine concentrations: the impact of obesity. Am. J. Perinatol. Rep. 06, e329–e336 (2016).
Kadakia, R. et al. Cord blood metabolites associated with newborn adiposity and hyperinsulinemia. J. Pediatrics 203, 144–9.e1 (2018).
Class, Q. A., Rickert, M. E., Lichtenstein, P. & D’Onofrio, B. M. Birth weight, physical morbidity, and mortality: a population-based sibling-comparison study. Am. J. Epidemiol. 179, 550–558 (2014).
Kramer, M. S. Determinants of low birth weight: methodological assessment and meta-analysis. Bull. World Health Organ. 65, 663–737 (1987).
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. Practice Bulletin No. 173: Fetal macrosomia. J. Obstet. Gynecol. 128, e195–e209 (2016).
Alsunnari, S. et al. Obstetric outcome of extreme macrosomia. J. Obstet. Gynaecol. Can. 27, 323–328 (2005).
Anoon, S. S., Rizk, D. E. E. & Ezimokhai, M. Obstetric outcome of excessively overgrown fetuses (>= 5000 g): a case-control study. J. Perinat. Med. 31, 295–301 (2003).
Hammami, M., Walters, J. C., Hockman, E. M. & Koo, W. W. Disproportionate alterations in body composition of large for gestational age neonates. J. Pediatr. 138, 817–821 (2001).
Lee, W. et al. The relationship of newborn adiposity to fetal growth outcome based on birth weight or the modified neonatal growth assessment score. J. Matern. Fetal Neonatal Med. 25, 1933–1940 (2012).
Boulet, S. L., Alexander, G. R., Salihu, H. M. & Pass, M. Macrosomic births in the united states: determinants, outcomes, and proposed grades of risk. Am. J. Obstet. Gynecol. 188, 1372–1378 (2003).
Vidarsdottir, H., Geirsson, R. T., Hardardottir, H., Valdimarsdottir, U. & Dagbjartsson, A. Obstetric and neonatal risks among extremely macrosomic babies and their mothers. Am. J. Obstet. Gynecol. 204, 423.e1–6 (2011).
Koyanagi, A. et al. Macrosomia in 23 developing countries: an analysis of a multicountry, facility-based, cross-sectional survey. Lancet 381, 476–483 (2013).
Bjorstad, A. R., Irgens-Hansen, K., Daltveit, A. K. & Irgens, L. M. Macrosomia: mode of delivery and pregnancy outcome. Acta Obstet. Gynecol. Scand. 89, 664–669 (2010).
Kain, J., Corvalan, C., Lera, L., Galvan, M. & Uauy, R. Accelerated growth in early life and obesity in preschool Chilean children. Obesity 17, 1603–1608 (2009).
Cnattingius, S., Villamor, E., Lagerros, Y. T., Wikström, A. K. & Granath, F. High birth weight and obesity-a vicious circle across generations. Int. J. Obes. 36, 1320–1324 (2012).
Sparano, S. et al. Being macrosomic at birth is an independent predictor of overweight in children: results from the IDEFICS study. Matern. Child Health J. 17, 1373–1381 (2013).
Sigurbjornsdottir, H. B. & Gunnarsdottir, B. E. Brjóstagjöf og næring ungbarna á Íslandi sem fædd eru 2004–2008 [Breastfeeding and Nutrition for Infants in Iceland Born in 2004–2008] (Directorate of Health in Iceland, 2012).
McHugh, D. et al. Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet. Med. 13, 230–254 (2011).
Bahn, C. Raising the bar on newborn screening test performance, July 24, 2017 (ed. Mayo Clinic Laboratories) https://news.mayocliniclabs.com/2017/07/24/raising-the-bar-on-newborn-screening-test-performance/ (2017).
Statistics Iceland. Live births and late fetal deaths by sex 1951–2018 http://www.statice.is/. (2019).
Biering, G., Snædal, G., Sigvaldason, H., Ragnarsson, J. & Geirsson, R. T. Size at birth in Iceland. Acta Paediatr. Scand. 319, 68–73 (1985).
Magi, S., Piccirillo, S. & Amoroso, S. The dual face of glutamate: from a neurotoxin to a potential survival factor-metabolic implications in health and disease. Cell Mol. Life Sci. 76, 1473–88. (2019).
Walker, M. C. & van der Donk, W. A. The many roles of glutamate in metabolism. J. Ind. Microbiol. Biotechnol. 43, 419–430 (2016).
Adeva-Andany, M. M., Perez-Felpete, N., Fernandez-Fernandez, C., Donapetry-Garcia, C. & Pazos-Garcia, C. Liver glucose metabolism in humans. Biosci. Rep. 36, e00416-e (2016).
Rui, L. Energy metabolism in the liver. Comp. Physiol. 4, 177–197 (2014).
Holm, M. B. et al. Uptake and release of amino acids in the fetal-placental unit in human pregnancies. PLoS ONE 12, e0185760 (2017).
Sanchez-Pintos, P. et al. Similarities between acylcarnitine profiles in large for gestational age newborns and obesity. Sci. Rep. 7, 16267 (2017).
Barker, D. J. et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36, 62–67 (1993).
Yu, Z. B. et al. Birth weight and subsequent risk of obesity: a systematic review and meta-analysis. Obes. Rev. 12, 525–542 (2011).
Acknowledgements
H.V. has received a doctoral grant from the University of Iceland Doctoral Grants Fund. Other authors have no financial support to disclose.
Author information
Affiliations
Contributions
All authors have met the Pediatric Research authorship requirements.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Vidarsdottir, H., Thorkelsson, T., Halldorsson, T.I. et al. Does metabolomic profile differ with regard to birth weight?. Pediatr Res 89, 1144–1151 (2021). https://doi.org/10.1038/s41390-020-1033-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41390-020-1033-0
Further reading
-
Relationships Between Placental Lipid Activated/Transport-Related Factors and Macrosomia in Healthy Pregnancy
Reproductive Sciences (2022)